1220811-27-7

Basic information

• Product Name: 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl 2,3-dichlorophenylcarbamate
• Synonyms: 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl 2,3-dichlorophenylcarbamate
• CAS NO: 1220811-27-7
• Molecular Weight: 406.312
• Mol File: 1220811-27-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl 2,3-dichlorophenylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl 2,3-dichlorophenylcarbamate(1220811-27-7)
• EPA Substance Registry System: 1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl 2,3-dichlorophenylcarbamate(1220811-27-7)

Safety Data

• Hazardous Substances Data: 1220811-27-7(Hazardous Substances Data)

Upstream product

• 41195-90-8 1,2-dichloro-3-isocyanatobenzene 
• 469-22-7 eseroline 

Relevant articles and documents

Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities

A series of physostigmine analogues were prepared and evaluated for cholinesterase inhibition activities, including acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Most of them showed potent inhibition activities against AChE, in which compound 17 especially exhibited significantly higher selectivity over BChE than phenserine, a compound currently on clinical trial. Discussion about the relationships between structure and activity of these derivatives was also presented.